Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002082 · ClinicalTrials.gov registry record · NA

Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study

A NA study of HIV Infections and Cryptosporidiosis, sponsored by Pfizer.

Completed
Registry status
NA
Development phase
4
Study locations

NCT00002082: Completed NA study of HIV Infections and Cryptosporidiosis, sponsored by Pfizer.

NCT00002082 is a NA study of HIV Infections and Cryptosporidiosis that has completed, run by Pfizer. The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002082, a NA study of HIV Infections and Cryptosporidiosis, has completed, sponsored by Pfizer.

COMPLETED
Registry status
NA
Development phase
4
Study locations

Study Summary

To evaluate the safety and efficacy of azithromycin in the treatment of intestinal cryptosporidial infection in AIDS patients.

Conditions Studied

HIV Infections Cryptosporidiosis

Interventions

  • DRUG Azithromycin

Study Locations (4)

California

  • Infectious Disease Med Group - Oakland
  • UCSD Med Ctr - San Diego

New York

  • Cornell Univ Med Ctr - New York

Tennessee

  • Univ of Tennessee - Memphis

Trial Details

FieldValue
Phase NA
Pfizer

1,845 total trials

What the finished NCT00002082 record still lists

NCT00002082 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Azithromycin is the first listed.

NCT00002082 reports a single indexed study location in California, New York, Tennessee.

Frequently Asked Questions

What is clinical trial NCT00002082 about?

NCT00002082 is a clinical study titled "Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study". To evaluate the safety and efficacy of azithromycin in the treatment of intestinal cryptosporidial infection in AIDS patients.

What is the current status of trial NCT00002082?

This trial is currently completed. It is a NA study.

What conditions does trial NCT00002082 study?

This clinical trial studies the following conditions: HIV Infections, Cryptosporidiosis.

What interventions are being tested in trial NCT00002082?

The interventions under investigation include: Azithromycin (DRUG).

Who is sponsoring clinical trial NCT00002082?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002082 being conducted?

This trial has 4 study locations across California, New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Related registry views

Source: ClinicalTrials.gov NCT00002082, the US trial registry maintained by the National Library of Medicine. NCT00002082 (unsized enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.